Liquid crystal nanoparticles could supercharge antibiotics for cystic fibrosis
Cystic fibrosis is the most common, life-limiting genetic condition in Australia. It affects the lungs, digestive system, and reproductive system, producing excess mucus, infections, and blockages.
